CHENODAL

This brand name is authorized in United States.

Active ingredients

The drug CHENODAL contains one active pharmaceutical ingredient (API):

`1`	Chenodeoxycholic acid UNII `0GEI24LG0J` - CHENODIOL
	Exogenous chenodeoxycholic acid is used as replacement therapy to restore the feedback inhibition lost due to the deficiency/absence of endogenous chenodeoxycholic acid. In CTX, deficiency of chenodeoxycholic acid causes a lack of feedback of cholesterol 7 alpha hydroxylase (CYP7A1) and HMG CoA reductase, causing increased production of atypical bile acids, bile alcohols and cholestanol that lead to the pathological consequences of the condition.
	Read more about Chenodeoxycholic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CHENODAL Film-coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	68974-876

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.